A
$ Value
$0
Shares
3,507
Price
$0
Filed
Aug 11
Insider
Name
Mulligan Seamus
Title
—
CIK
0001536639
Roles
Director
Transaction Details
Transaction Date
2025-08-07
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,179,613
Footnotes
These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026. | Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.